Home LiteratureArticle Details

PMID: 9189180 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

Cancer treatment reviews ·Vol. 23 ·No. 1 ·1997-01-00 ·Pages 35-61

Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C

Abstract

暂无摘要

MeSH Terms

Adult Animals Antineoplastic Agents, Alkylating/chemistry,pharmacology Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Dacarbazine/analogs & derivatives,chemistry,pharmacology Female Humans Male Middle Aged Neoplasms, Experimental/drug therapy Temozolomide Tumor Cells, Cultured/drug effects

Chemicals

Antineoplastic Agents, Alkylating Dacarbazine Temozolomide

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Newlands E S

Department of Medical Oncology, Charing Cross Hospital, London, U.K.

Stevens M F

Wedge S R

Wheelhouse R T

Brock C

Article Info

Journal

Cancer treatment reviews

Abbr.

Cancer Treat Rev

ISSN

0305-7372

DOI

10.1016/s0305-7372(97)90019-0

Published

1997-01-00

Pages

35-61

Language

English

Region

Netherlands

NLM ID

7502030

Subset

External Links

PubMed source DOI: 10.1016/s0305-7372(97)90019-0 View journal details

Analysis Services

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

Contact

WeChat Official Account